The Association for Professionals in Infection Control and Epidemiology (APIC) today announced the launch of APIC Consulting Services, Inc. (ACSI), a full-service consulting company specializing in infection prevention and control. A wholly owned, for-profit subsidiary of APIC, ACSI will work with acute, ambulatory and long-term care facilities, hospital systems, insurance companies and government organizations to advance infection prevention.
“ACSI was developed as a way to help healthcare facilities and other entities responsible for infection prevention solve their largest and most urgent issues,” said ACSI CEO Kathy L. Warye. “Our international network of leading infection preventionists allows us to quickly mobilize the expertise necessary to tackle an array of issues.”
ACSI’s three primary lines of business include development of programs to reduce multi-drug resistant organisms (e.g., MRSA, C. difficile), outbreak recovery and preparation for state and federal regulatory compliance and accreditation. ACSI consultants have experience in all aspects of infection prevention and control, from emerging pathogens to surveillance technology assessment to construction issues.
APIC’s extensive library of infection prevention resources, including the evidence-based elimination guides for MRSA, C. difficile and catheter-related bloodstream infections, forms the basis of ACSI’s consulting practice. APIC materials are rooted in science-based best practices, developed in consensus with leading infection preventionists and CDC input.
“The need has never been greater for healthcare institutions to reduce HAIs,” said Warye. “As the global leader in infection prevention, APIC is uniquely positioned to offer critical expertise that will not only help facilities reduce infections, but also improve the bottom line.”
For more information, visit http://www.apicconsulting.com or call (202) 464-4252.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.